These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35124372)

  • 1. TOPBP1 regulates resistance of gastric cancer to oxaliplatin by promoting transcription of PARP1.
    Fang Z; Gong C; Ye Z; Wang W; Zhu M; Hu Y; Liu Z; Zhou W; Li H
    DNA Repair (Amst); 2022 Mar; 111():103278. PubMed ID: 35124372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.
    Li H; Wang C; Lan L; Yan L; Li W; Evans I; Ruiz EJ; Su Q; Zhao G; Wu W; Zhang H; Zhou Z; Hu Z; Chen W; Oliveira JM; Behrens A; Reis RL; Zhang C
    Cell Mol Life Sci; 2022 Feb; 79(3):135. PubMed ID: 35179655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA topoisomerase IIbeta binding protein 1 (TopBP1) interacts with poly (ADP-ribose) polymerase (PARP-1).
    Wollmann Y; Schmidt U; Wieland GD; Zipfel PF; Saluz HP; Hänel F
    J Cell Biochem; 2007 Sep; 102(1):171-82. PubMed ID: 17340632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small-molecule inhibitor of TopBP1 exerts anti-MYC activity and synergy with PARP inhibitors.
    Lin FT; Liu K; Garan LAW; Folly-Kossi H; Song Y; Lin SJ; Lin WC
    Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2307793120. PubMed ID: 37878724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer.
    Tang X; Liang Y; Sun G; He Q; Hou Z; Jiang X; Gao P; Qu H
    Cell Death Dis; 2022 Oct; 13(10):848. PubMed ID: 36195596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP1: A potential biomarker for gastric cancer.
    Afzal H; Yousaf S; Rahman F; Ahmed MW; Akram Z; Akhtar Kayani M; Mahjabeen I
    Pathol Res Pract; 2019 Aug; 215(8):152472. PubMed ID: 31174925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma.
    Que KT; Zhou Y; You Y; Zhang Z; Zhao XP; Gong JP; Liu ZJ
    J Exp Clin Cancer Res; 2018 Nov; 37(1):268. PubMed ID: 30400960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity.
    Moudry P; Watanabe K; Wolanin KM; Bartkova J; Wassing IE; Watanabe S; Strauss R; Troelsgaard Pedersen R; Oestergaard VH; Lisby M; Andújar-Sánchez M; Maya-Mendoza A; Esashi F; Lukas J; Bartek J
    J Cell Biol; 2016 Feb; 212(3):281-8. PubMed ID: 26811421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TopBP1 promotes malignant progression and correlates with poor prognosis in osteosarcoma.
    Wu DP; Yan XB; Liu LG; Tian C; Han K; Zhang H; Min DL
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4022-4031. PubMed ID: 29028101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer.
    Huang W; Han Z; Sun Z; Feng H; Zhao L; Yuan Q; Chen C; Yu S; Hu Y; Yu J; Liu H; Li G; Jiang Y
    Cell Death Dis; 2022 Jul; 13(7):658. PubMed ID: 35902562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil enhances the sensitivity of oxaliplatin to tumor cells by influencing the PARP pathway.
    Zhang T; Yang G; Liu Y; Fan P
    Pharmazie; 2019 Dec; 74(12):740-743. PubMed ID: 31907114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
    Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
    Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2.
    Kim J; Pyun JA; Cho SW; Lee K; Kwack K
    DNA Cell Biol; 2011 Dec; 30(12):1011-7. PubMed ID: 21612407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PARP1 activity enhances chemotherapeutic efficiency in cisplatin-resistant gastric cancer cells.
    Wang Q; Xiong J; Qiu D; Zhao X; Yan D; Xu W; Wang Z; Chen Q; Panday S; Li A; Wang S; Zhou J
    Int J Biochem Cell Biol; 2017 Nov; 92():164-172. PubMed ID: 28827033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer.
    Lin C; Lin P; Yao H; Liu S; Lin X; He R; Teng Z; Zuo X; Li Y; Ye J; Zhu G
    Cancer Lett; 2024 Apr; 587():216712. PubMed ID: 38364962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights from the crystal structure of the sixth BRCT domain of topoisomerase IIbeta binding protein 1.
    Leung CC; Kellogg E; Kuhnert A; Hänel F; Baker D; Glover JN
    Protein Sci; 2010 Jan; 19(1):162-7. PubMed ID: 19937654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
    Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53.
    Lv Y; Huo Y; Yu X; Liu R; Zhang S; Zheng X; Zhang X
    Drug Des Devel Ther; 2016; 10():3053-3064. PubMed ID: 27729767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
    Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
    Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition.
    Raspaglio G; Buttarelli M; Filippetti F; Battaglia A; Buzzonetti A; Scambia G; Gallo D
    Cell Death Dis; 2021 Oct; 12(10):933. PubMed ID: 34642300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.